Literature DB >> 2927166

Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults.

M Riquet1, G Hidden, B Debesse.   

Abstract

The subpleural lymphatics of 483 lung segments were injected in cadavers of 260 adult subjects. The injected lymph vessels corresponded to the pulmonary segmentation in 91% of the cases and remained close by in the other cases. Direct passages to the mediastinal nodes were observed in 54 of 243 right lung segments injected (22.2%) and 60 of 240 left lung segments (25%). Among a total of 114 direct passages observed, 99 remained superficial in the pleura, half of them composed of a single vessel. These passages have been observed more frequently in the segments of the upper lobes. Injections of basal segments in the right and left lower lobes showed fewer of these direct passages to the mediastinal lymph nodes and also demonstrated direct lymph vessels to lymph nodes located at the origin of the upper lobar bronchi. In two dissections of the right upper lobe, the drainage went directly to the right venous jugular-subclavian junction, and in three dissections from three right terminal basal segments the lymph vessel went directly to the thoracic duct in its mediastinal passage. Direct contralateral lymph pathways were observed five times, four of them from basal segments of lower lobes.

Mesh:

Substances:

Year:  1989        PMID: 2927166

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  28 in total

Review 1.  Last-intercalated node and direct lymphatic drainage into the thoracic duct from the thoracoabdominal viscera.

Authors:  Gen Murakami; Masato Abe; Tomio Abe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

2.  Lymphatic drainage of the middle lobe of the adult lung.

Authors:  M Riquet; P Dupont; G Hidden; B Debesse
Journal:  Surg Radiol Anat       Date:  1990       Impact factor: 1.246

3.  Early recurrence of completely resected N2-positive non-small-cell lung cancer.

Authors:  Takuma Tsukioka; Noritoshi Nishiyama; Takashi Iwata; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Kiyotoshi Inoue; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-03

4.  From anatomy to lung cancer: questioning lobe-specific mediastinal lymphadenectomy reliability.

Authors:  Marc Riquet; Ciprian Pricopi; Alex Arame; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Can mathematics replace anatomy to establish recommendations in lung cancer surgery?

Authors:  Marc Riquet; Ciprian Pricopi; Antoine Legras; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.

Authors:  J Jin; Y Xu; X Hu; M Chen; M Fang; Q Hang; M Chen
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

7.  Lymphatic drainage of lung segments in the visceral pleura: a cadaveric study.

Authors:  Alex Fourdrain; Sophie Lafitte; Jules Iquille; Florence De Dominicis; Eric Havet; Johann Peltier; Patrick Bagan; Pascal Berna
Journal:  Surg Radiol Anat       Date:  2017-08-19       Impact factor: 1.246

8.  Adequacy of intra-operative nodal staging during lung cancer surgery: a poorly achieved minimum objective.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

9.  Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastasis.

Authors:  N Lee; K Inoue; R Yamamoto; H Kinoshita
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

10.  Analysis of factors influencing skip lymphatic metastasis in pN(2) non-small cell lung cancer.

Authors:  Gui-Long Li; Yong Zhu; Wei Zheng; Chao-Hui Guo; Chun Chen
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.